Alan Huang Joins Polarean Imaging as VP of Sales

Polarean Imaging plc has named Alan Huang, Ph.D., as vice president of Sales.
 
Dr. Huang has 15 years of experience in the medical device industry, with specific expertise in magnetic resonance imaging (MRI) and MRI-based technologies. He is skilled in executing strategic plans and driving revenue growth of novel technologies. Dr. Huang joins Polarean after nearly 12 years at Philips Healthcare, where he held various roles, most recently as North American Business Leader for the MRI business unit. In this role, he was directly responsible for P&L management and directing the sales and marketing teams. Dr. Huang also developed strategic plans for market growth, supported the reorganization of the commercial organization to sharpen its focus on key markets, and hired channel partners to assist in the management of the business in non-core markets.

“I am extremely delighted to welcome Alan to the Polarean team as our vice president of Sales. Having gotten to know him over the past year during our collaboration with Philips, I am confident that he brings a wealth of experience and insights that will greatly complement our current commercial team,” Polarean CEO Christopher von Jako, Ph.D., said. “This appointment comes at an ideal time following our recent financing, as we aim to expand our sales infrastructure with best-in-class talent to accelerate the adoption of our Xenon MRI technology. Alan’s extensive experience at Philips, where he successfully grew their MR business and built strong relationships with a large number of academic medical centers and clinicians across the US, makes him a tremendous asset to Polarean.”
 
As vice president of Sales, Dr. Huang will be responsible for driving Polarean’s sales strategy and leading the company’s expanding sales team as it accelerates the market adoption of its pulmonary functional Xenon MRI platform technology. He will focus on expanding the technology’s footprint in academic medical centers and driving utilization across the growing install base, enabling improved characterization and management of chronic lung disease for patients and their clinicians.
 
Dr. Huang earned a Ph.D. in biomedical engineering from Johns Hopkins University School of Medicine in Baltimore, Md., and a double bachelor of science degree in neurobiology and electrical and computer engineering from the University of Texas at Austin.
 
“In my previous roles in diagnostic MRI and Radiation Therapy solutions, I recognized the potential of Polarean’s Xenon MRI technology to significantly improve the characterization and management of chronic lung diseases,” Dr. Huang stated. “Through the Philips partnership with Polarean and numerous conversations with customers, I became more aware of the significant unmet clinical need and was impressed by the company’s approach. I am excited to join Polarean and work with the team to expand the reach of Xenon MRI platform technology across the pulmonary clinical community.”

Polarean is a revenue-generating medical imaging technology company revolutionizing pulmonary medicine through direct visualization of lung function by introducing the power and safety of MRI to the respiratory healthcare community. This community is in desperate need of modern solutions to accurately assess lung function. The company strives to optimize lung health and prevent avoidable loss by illuminating hidden disease, addressing the global unmet medical needs of more than 500 million patients worldwide suffering from chronic respiratory disease. Polarean is a leader in the field of hyperpolarization science and has successfully developed the first and only hyperpolarized Xenon MRI inhaled contrast agent, XENOVIEW, which is now approved by the U.S. Food and Drug Administration. Polarean researches, develops, and commercializes imaging solutions with its non-invasive and radiation-free pulmonary functional MRI platform. This drug-device platform encompasses the proprietary Xenon gas blend, gas hyperpolarization system, as well as software and accessories, facilitating fully integrated modern respiratory imaging operations. Founded in 2012, with offices in Durham, N.C., and London, United Kingdom, Polarean aims to increase global awareness of and broad access to its XENOVIEW MRI technology platform.